Treatment with Venetoclax Positively Modulates Immunological Parameters and T-Cell Features in Patients with Chronic Lymphocytic LeukemiaValentina Griggio, Marta Coscia, Giulia Bondielli et al.|Blood|2024Cited by 1
Venetoclax-based therapy remodels T-cell and NK-cell immunity in patients with chronic lymphocytic leukemiaGiorgia Mancin, Marta Coscia, Valentina Griggio et al.|Blood|2025Cited by 0